Xeris Biopharma Holdings, Inc. (XERS)
6.095
+0.06
(+0.91%)
USD |
NASDAQ |
Apr 06, 11:02
Xeris Biopharma Holdings Market Cap : 1.051B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| IDEXX Laboratories, Inc. | 46.16B |
| Zoetis, Inc. | 50.04B |
| Harrow, Inc. | 1.312B |
| Zymeworks, Inc. | 1.950B |
| Vir Biotechnology, Inc. | 1.467B |
Market Cap Related Metrics
| PS Ratio | 3.496 |
| Price to Book Value | 76.77 |
| Price to Free Cash Flow | 36.53 |
| Price | 6.095 |
| Earnings Yield | -0.12% |
| Operating PE Ratio | 40.98 |